Clinical Trial Detail

NCT ID NCT02496585
Title Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies

Nintedanib

Prednisone

Age Groups: adult

No variant requirements are available.